Innerer Wert von S&P & Nasdaq Kontaktieren

Paragon 28, Inc. FNA NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
36/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$13.00
-0.7%

Paragon 28, Inc. (FNA) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Englewood, CO, United States. Der aktuelle CEO ist Albert DaCosta.

FNA hat IPO-Datum 2021-10-15, 525 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $1.1B.

Über Paragon 28, Inc.

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

📍 14445 Grasslands Drive, Englewood, CO 80112 📞 730 399 3400
Unternehmensdetails
SektorGesundheitswesen
BrancheMedical - Devices
LandUnited States
BörseNYSE
WährungUSD
IPO-Datum2021-10-15
CEOAlbert DaCosta
Mitarbeiter525
Handelsinformationen
Aktueller Kurs$13.09
Marktkapitalisierung$1.1B
52-Wochen-Spanne4.65-13.13
Beta1.47
ETFNein
ADRNein
CUSIP69913P105
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden